دواعي استعمال تيراسين 5مجم 10 كبسول
معلومات من نشرات دوائية ومراجع موثقة، مع مصدر كل معلومة. السعر الحالي: 14.4ج.م.
عن الدواء
Terazosin 5 mg capsules, pack of 10 (Technopharm, Egypt); alpha-1 adrenoceptor blocker.
دواعي الاستعمال
- Treatment of symptomatic benign prostatic hyperplasia (BPH).DailyMed (U.S. National Library of Medicine)
- Treatment of hypertension, alone or with other antihypertensives.DailyMed (U.S. National Library of Medicine)
الآثار الجانبية
- BPH trials: asthenia, postural hypotension, dizziness, somnolence, nasal congestion/rhinitis and impotence were significantly more common than placebo.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
موانع الاستعمال
- Known hypersensitivity to terazosin hydrochloride.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
تحذيرات واحتياطات
- Syncope and first-dose effect: marked postural hypotension and syncope may occur with the first dose(s), after interruption, rapid dose increase or addition of another antihypertensive.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
- Priapism has rarely been reported; requires prompt treatment to avoid permanent impotence.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
التداخلات الدوائية
- Verapamil and other antihypertensivesCaution with other antihypertensives, especially verapamil (terazosin AUC increased); dose reduction and retitration may be needed.DailyMed (U.S. National Library of Medicine)
- PDE-5 inhibitorsHypotension has been reported with concomitant PDE-5 inhibitors.DailyMed (U.S. National Library of Medicine)
الحمل والرضاعة
- Not teratogenic in rats or rabbits; no adequate and well-controlled studies in pregnant women.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
- Not known whether excreted in breast milk; use caution in nursing women.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
المصادر
- السعر: قوائم أسعار الأدوية المنشورة في مصر.
- DailyMed (U.S. National Library of Medicine)
- WHO Collaborating Centre for Drug Statistics Methodology